Expanding controlled donation after the circulatory determination of death: statement from an international collaborative. This International Collaborative Statement aims at expanding cDCDD in the world to help countries progress towards self-sufficiency in transplantation and offer more patients the opportunity of organ donation. The Statement addresses three fundamental aspects of the cDCDD pathway:
- First, it describes the process of determining a prognosis that justifies the WLST (withdrawal of life-supporting therapies).
- Second, it establishes the permanent cessation of circulation to the brain as the standard to determine death by circulatory criteria.
- Finally, the Statement highlights the value of perfusion repair for increasing the success of cDCDD organ transplantation.
Prof Giuseppe CITERIO. Associate Professor, School of Medicine and Surgery of the University of Milano-Bicocca in Monza, (IT); director of the NeuroIntensive Care Unit, San Gerardo Hospital in Monza (IT).
Prof Francis L. DELMONICO. Chief Medical Officer, New England Donor Services (US), Professor at Harvard Medical School at Massachusetts General Hospital and Emeritus Director of Renal Transplantation.
Dr Beatriz DOMÍNGUEZ-GIL. General Director, Organización Nacional de Trasplantes, Madrid (ES).